Related references
Note: Only part of the references are listed.Taranabant cuts the fat: New hope for Cannabinoid-based obesity therapies?
Tim C. Kirkham
CELL METABOLISM (2008)
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy et al.
CELL METABOLISM (2008)
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: Results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers
Carol Addy et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats
Mohammed Shoaib
NEUROPHARMACOLOGY (2008)
Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
V. Kiran Vemuri et al.
PHYSIOLOGY & BEHAVIOR (2008)
The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats
Kelly S. Sink et al.
NEUROPSYCHOPHARMACOLOGY (2008)
GPR55: a new member of the cannabinoid receptor clan?
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
J. M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Treatment of tobacco dependence: integrating recent progress into practice
Bernard Le Foll et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling
E. Kodas et al.
PSYCHOPHARMACOLOGY (2007)
Cannabinoid CB1 receptor inverse agonists and neutral antagonists:: Effects on food intake, food-reinforced behavior and food aversions
John D. Salamone et al.
PHYSIOLOGY & BEHAVIOR (2007)
Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex
Valentina Bassareo et al.
PSYCHOPHARMACOLOGY (2007)
High Reinforcing Efficacy of Nicotine in Non-Human Primates
Bernard Le Foll et al.
PLOS ONE (2007)
Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation
Joseph F. Cheer et al.
JOURNAL OF NEUROSCIENCE (2007)
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats
Benoit Forget et al.
PSYCHOPHARMACOLOGY (2006)
Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats:: Role of glutamate in the nucleus accumbens
Zheng-Xiong Xi et al.
JOURNAL OF NEUROSCIENCE (2006)
Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine
Megan J. Shram et al.
PSYCHOPHARMACOLOGY (2006)
Reinstatement of nicotine-conditioned place preference by drug priming: Effects of calcium channel antagonists
Grazyna Biala et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The role of the basolateral amygdala in stimulus-reward memory and extinction memory consolidation and in subsequent conditioned cued reinstatement of cocaine seeking
Rita A. Fuchs et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice
CL Walters et al.
PSYCHOPHARMACOLOGY (2006)
Nicotine as a typical drug of abuse in experimental animals and humans
B Le Foll et al.
PSYCHOPHARMACOLOGY (2006)
Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists
SD Grabus et al.
PSYCHOPHARMACOLOGY (2006)
Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats
Marcello Solinas et al.
NATURE PROTOCOLS (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats
B Forget et al.
PSYCHOPHARMACOLOGY (2005)
Cannabinoid CB1 receptors control conditioned drug seeking
TJ De Vries et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
U Maskos et al.
NATURE (2005)
Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A
TJ De Vries et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Endocannabinoid release from midbrain dopamine neurons: A potential substrate for cannabinoid receptor antagonist treatment of addiction
CR Lupica et al.
NEUROPHARMACOLOGY (2005)
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans
B Le Foll et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
CB1 receptor antagonists for the treatment of nicotine addiction
C Cohen et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Evidence for novel cannabinoid receptors
M Begg et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Nicotine induces conditioned place preferences over a large range of doses in rats
B Le Foll et al.
PSYCHOPHARMACOLOGY (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: Reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)
C Cohen et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Dopamine operates as a subsecond modulator of food seeking
MF Roitman et al.
JOURNAL OF NEUROSCIENCE (2004)
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
B Le Foll et al.
NEUROREPORT (2004)
Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics
SM Grüsser et al.
PSYCHOPHARMACOLOGY (2004)
Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area
AC Riegel et al.
JOURNAL OF NEUROSCIENCE (2004)
Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats
JD Belluzzi et al.
PSYCHOPHARMACOLOGY (2004)
Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming
MG LeSage et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement
EC Donny et al.
PSYCHOPHARMACOLOGY (2003)
Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats
J McLaughlin et al.
PSYCHOPHARMACOLOGY (2003)
Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior
M Andreoli et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: Implications for studies of natural motivation, psychiatry, and drug abuse
JD Salamone et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Brain metabolic changes during cigarette craving
AL Brody et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Importance of nonpharmacological factors in nicotine self-administration
AR Caggiula et al.
PHYSIOLOGY & BEHAVIOR (2002)
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
S González et al.
BRAIN RESEARCH (2002)
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence
A Castañé et al.
NEUROPHARMACOLOGY (2002)
Nicotine-induced conditioned place preference in adolescent and adult rats
BJ Vastola et al.
PHYSIOLOGY & BEHAVIOR (2002)
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
C Cohen et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
D Robbe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice
B Le Foll et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats
N Lindblom et al.
RESPIRATION (2002)
Neuroscience - Endocannabinoid signaling in the brain
RI Wilson et al.
SCIENCE (2002)
Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization
L Lu et al.
PSYCHOPHARMACOLOGY (2002)
The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion
M Shoaib et al.
NEUROPHARMACOLOGY (2002)
Cue dependency of nicotine self-administration and smoking
AR Caggiula et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Conditioned fear stimuli reinstate cocaine-induced conditioned place preference
CJ Sanchez et al.
BRAIN RESEARCH (2001)
Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence:: Reversal by D1 antagonists
R Ciccocioppo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
G Cossu et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
MT Bardo et al.
PSYCHOPHARMACOLOGY (2000)
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
G Tanda et al.
NATURE NEUROSCIENCE (2000)
Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction
D Mueller et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Control of cocaine-seeking behavior by drug-associated stimuli in rats: Effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens
F Weiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats
M Shoaib et al.
PSYCHOPHARMACOLOGY (2000)
Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation
RW Jeffery et al.
HEALTH PSYCHOLOGY (2000)
Role of dopamine in the behavioural actions of nicotine related to addiction
G Di Chiara
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Effects of chronic Delta(9)-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment
XF Wu et al.
NEUROPHARMACOLOGY (2000)